Is combining methotrexate and leflunomide a safe option for treating rheumatoid arthritis?
Rheumatoid arthritis (RA) is a chronic immune-mediated disease marked by synovial inflammation and systemic features. Early management typically relies on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), with methotrexate (Mtx) serving as the primary therapeutic agent. When M...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Society of Turaz Bilim
2025-04-01
|
| Серии: | Medicine Science |
| Предметы: | |
| Online-ссылка: | https://www.medicinescience.org/?mno=257946 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
